"Die Klinik für Frauenheilkunde und Geburtshilfe der Gesundheit Nordhessen bietet Ihnen eine umfassende und kompetente Versorgung bei allen Krankheitsbildern. Als hochspezialisierte Kasseler Frauenklinik decken wir das gesamte Leistungsspektrum der konservativen und operativen Gynäkologie ab. Von der ausführlichen Aufklärung über Ihre Operation und den Ablauf von Behandlung oder Geburt bis zur Entlassung begegnen wir Ihnen auf Augenhöhe. Unser Selbstverständnis für eine vertrauensvolle Beziehung zwischen Ärztinnen, Ärzten, Pflegepersonal und Ihnen als Patientin geht dabei weit über die körperliche Behandlung hinaus: Wir stellen die Weichen für Ihr Wohlbefinden."

During the past decade, Klinikum Kassel GmbH, Gynäkologische Ambulanz conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Kassel GmbH, Gynäkologische Ambulanz" #1 collaborator was "Austrian Breast & Colorectal Cancer Study Group" with 2 trials as a collaborator, "Cancer Trials Ireland" with 1 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "Novartis Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Klinikum Kassel GmbH, Gynäkologische Ambulanz" are "Breast Cancer" (1 trials), "HER2-negative Breast Cancer" (1 trials) and "Triple Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Klinikum Kassel GmbH, Gynäkologische Ambulanz" in a lesser frequency.

Most popular intervention types in "Klinikum Kassel GmbH, Gynäkologische Ambulanz" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Capecitabine" (1 trials), "Carboplatin" (1 trials), "Cisplatin" (1 trials), "Sacituzumab govitecan" (1 trials) and "Zoledronic acid" (1 trials). Other intervention names were less common.

The vast majority of trials in "Klinikum Kassel GmbH, Gynäkologische Ambulanz" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Klinikum Kassel GmbH, Gynäkologische Ambulanz". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Klinikum Kassel GmbH, Gynäkologische Ambulanz, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Klinikum Kassel GmbH, Gynäkologische Ambulanz, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".